Stuart Montgomery

Research interests

Publications

• Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone

  European Neuropsychopharmacology · 2019 · 10.1016/j.euroneuro.2019.06.008

• Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice

  The World Journal of Biological Psychiatry · 2019 · 10.1080/15622975.2019.1635270

• Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

  Acta Psychiatrica Scandinavica · 2018 · 10.1111/acps.12959

• A comparative review of escitalopram, paroxetine, and sertraline

  International Clinical Psychopharmacology · 2014 · 10.1097/yic.0000000000000023

• A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine

  Human Psychopharmacology Clinical and Experimental · 2014 · 10.1002/hup.2424

• Humanistic and economic burden of generalized anxiety disorder in North America and Europe

  Journal of Affective Disorders · 2011 · 10.1016/j.jad.2011.11.014

• A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder

  International Clinical Psychopharmacology · 2008 · 10.1097/yic.0b013e32830263de

• Which antidepressants have demonstrated superior efficacy? A review of the evidence

  International Clinical Psychopharmacology · 2007 · https://doi.org/10.1097/yic.0b013e3282eff7e0

• Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder

  The Journal of Clinical Psychiatry · 2007 · 10.4088/jcp.v68n0713

• Efficacy and Safety of Pregabalin in the Treatment of Generalized Anxiety Disorder

  The Journal of Clinical Psychiatry · 2006 · 10.4088/jcp.v67n0511

• Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder

  Biological Psychiatry · 2005 · 10.1016/j.biopsych.2005.07.013

• Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study

  International Clinical Psychopharmacology · 2004 · 10.1097/01.yic.0000137184.64610.c8

• A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder

  Neuropsychobiology · 2004 · 10.1159/000078225

• WCA Recommendations for the Long-Term Treatment of Obsessive-Compulsive Disorder in Adults

  CNS Spectrums · 2003 · 10.1017/s1092852900006908

• Partial Response and Nonresponse to Antidepressant Therapy

  The Journal of Clinical Psychiatry · 2002 · 10.4088/jcp.v63n0913

• Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

  International Clinical Psychopharmacology · 2001 · 10.1097/00004850-200103000-00002

• Escitalopram (S-Enantiomer of Citalopram): Clinical Efficacy and Onset of Action Predicted from a Rat Model

  Pharmacology & Toxicology · 2001 · 10.1034/j.1600-0773.2001.d01-118.x

• Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey

  International Clinical Psychopharmacology · 2000 · 10.1097/00004850-200015060-00002

• Social Functioning in Depression

  The Journal of Clinical Psychiatry · 2000 · https://doi.org/10.4088/jcp.v61n0405

• Treatment resistant depression: methodological overview and operational criteria

  European Neuropsychopharmacology · 1999 · 10.1016/s0924-977x(98)00004-2

• Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia

  Journal of Affective Disorders · 1997 · 10.1016/s0165-0327(96)01405-x

• A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression

  International Clinical Psychopharmacology · 1993 · 10.1097/00004850-199300830-00008

• Pharmacological prevention of suicidal behaviour

  Journal of Affective Disorders · 1982 · 10.1016/0165-0327(82)90026-x

• A New Depression Scale Designed to be Sensitive to Change

  The British Journal of Psychiatry · 1979 · https://doi.org/10.1192/bjp.134.4.382

• A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE

  Acta Psychiatrica Scandinavica · 1978 · https://doi.org/10.1111/j.1600-0447.1978.tb02357.x

Current projects

No projects listed.